U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07565597) titled 'A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.' on April 27.
Brief Summary: This study will compare the pharmacokinetics (PK) effect of two different formulations of Gecacitinib Hydrochloride Tablets in healthy Adult participants
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Gecacitinib Hydrochloride Tablets
Administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....